INTELLIGENT BIO SOLUTIONS INC. Payments for Repurchase of Initial Public Offering
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Payments for Repurchase of Initial Public Offering of $2.00 million for the 12-month period ending 2021-06-30, per its 10-K filed 2021-09-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfInitialPublicOffering · last filed 2021-09-16
- INTELLIGENT BIO SOLUTIONS INC. payments for repurchase of initial public offering for the quarter ending 2021-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments for repurchase of initial public offering for the quarter ending 2021-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments for repurchase of initial public offering for the quarter ending 2020-06-30 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments for repurchase of initial public offering for the quarter ending 2020-03-31 was $0.00.
- INTELLIGENT BIO SOLUTIONS INC. payments for repurchase of initial public offering for fiscal 2021 was $2.00M, a 1621.58% increase from fiscal 2020.
- INTELLIGENT BIO SOLUTIONS INC. payments for repurchase of initial public offering for fiscal 2020 was $116.40K.
| Period end | Payments for Repurchase of Initial Public Offering 3 month | Payments for Repurchase of Initial Public Offering 6 month | Payments for Repurchase of Initial Public Offering 9 month | Payments for Repurchase of Initial Public Offering 12 month |
|---|---|---|---|---|
| 2021-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $0.00 derived: sum of 2 quarters · filed 2021-09-16 | $2.00M 10-K · filed 2021-09-16 | |
| 2021-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $2.00M 10-Q · filed 2021-05-13 | ||
| 2020-12-31 | $2.00M 10-Q · filed 2021-02-12 | |||
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-16 | $0.00 derived: sum of 2 quarters · filed 2021-09-16 | $116.40K 10-K · filed 2021-09-16 | |
| 2020-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-05-13 | $116.40K 10-Q · filed 2021-05-13 | ||
| 2019-12-31 | $116.40K 10-Q · filed 2021-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |